Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

NASDAQ:DRTS

Alpha Tau Medical Ltd.

Last Close

2.13

26/07 20:00

Market Cap

152.16M

Beta: 1.03

Volume Today

5.60K

Avg: 36.38K

PE Ratio

−8.90

PFCF: −36.22

Institutional trades

Institutional Ownership

Current holdings institutionals